Shimabukuro et al
Melanoma Research 21 (2) April 2011
ISSN: 0960-8931 • Frequency: 6/year • Subscribe Now
This study aims to assess the basal DNA damage in peripheral blood leukocytes of patients with melanoma at an early stage, and assess, in vitro, the response to cisplatin in the leukocytes of the same patients and cancer-free controls using the Comet assay.
Read this Introduction / Read this Article
Don't miss out - further Free LWW Content is available for registered users! Log into your account or register here to read these articles